Oculocutaneous albinism types 1 and 3 are ER retention diseases: mutation of tyrosinase or Tyrp1 can affect the processing of both mutant and wild-type proteins

被引:124
作者
Toyofuku, K
Wada, I
Valencia, JC
Kushimoto, T
Ferrans, VJ
Hearing, VJ
机构
[1] NCI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA
[2] Sapporo Med Univ, Dept Biochem, Sapporo, Hokkaido, Japan
[3] NHLBI, Pathol Sect, NIH, Bethesda, MD 20892 USA
关键词
albinism; chaperones; pigmentation; melanogenesis;
D O I
10.1096/fj.01-0216com
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Various types of oculocutaneous albinism (OCA) are associated with reduced pigmentation in the skin, hair, and eyes that results from mutations in genes involved in melanin synthesis. Immortal mouse melanocyte lines (melan-a, melan-b, and melan-c) provide opportune models with which to investigate the etiology of two different types of OCA (types I and III), which arise from mutations in Tyr and Tyrp1, respectively. We compared intracellular processing, sorting, and degradation of tyrosinase and Tyrp1, and the effects on their catalytic function and melanin synthesis, in these wild-type and mutant melanocytes. A mutation in either Tyr or Tyrp1 increased the time of association of tyrosinase and Tyrp1 with calnexin and Bip, which in turn resulted in the retention of these mutant products in the ER. A mutation in either gene selectively enhanced the duration and efficiency of chaperone interactions (even with the wild-type protein in the mutant melanocytes) and markedly slowed their transport to melanosomes. These results show that OCA1 and OCA3 are (in some cases, at least) ER retention diseases wherein a mutation in one melanogenic protein affects the maturation and stability of the other in the melanogenic pathway.
引用
收藏
页码:2149 / 2161
页数:13
相关论文
共 68 条
[1]  
Allen S, 2000, BLOOD, V96, P560
[2]  
[Anonymous], 1979, COAT COLORS MICE MOD
[3]  
BENNETT DC, 1989, DEVELOPMENT, V105, P379
[4]   A LINE OF NONTUMORIGENIC MOUSE MELANOCYTES, SYNGENEIC WITH THE B-16 MELANOMA AND REQUIRING A TUMOR PROMOTER FOR GROWTH [J].
BENNETT, DC ;
COOPER, PJ ;
HART, IR .
INTERNATIONAL JOURNAL OF CANCER, 1987, 39 (03) :414-418
[5]   A common temperature-sensitive allelic form of human tyrosinase is retained in the endoplasmic reticulum at the nonpermissive temperature [J].
Berson, JF ;
Frank, DW ;
Calvo, PA ;
Bieler, BM ;
Marks, MS .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (16) :12281-12289
[6]   AFFINITY PANNING OF A LIBRARY OF PEPTIDES DISPLAYED ON BACTERIOPHAGES REVEALS THE BINDING-SPECIFICITY OF BIP [J].
BLONDELGUINDI, S ;
CWIRLA, SE ;
DOWER, WJ ;
LIPSHUTZ, RJ ;
SPRANG, SR ;
SAMBROOK, JF ;
GETHING, MJH .
CELL, 1993, 75 (04) :717-728
[7]  
Boissy RE, 1996, AM J HUM GENET, V58, P1145
[8]   Human tyrosinase related protein-1 (TRP-1) does not function as a DHICA oxidase activity in contrast to murine TRP-1 [J].
Boissy, RE ;
Sakai, C ;
Zhao, HQ ;
Kobayashi, T ;
Hearing, VJ .
EXPERIMENTAL DERMATOLOGY, 1998, 7 (04) :198-204
[9]   Mutations at critical N-glycosylation sites reduce tyrosinase activity by altering folding and quality control [J].
Branza-Nichita, N ;
Negroiu, G ;
Petrescu, AJ ;
Garman, EF ;
Platt, FM ;
Wormald, MR ;
Dwek, RA ;
Petrescu, SM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (11) :8169-8175
[10]   Tyrosinase folding and copper loading in vivo:: A crucial role for calnexin and α-glucosidase II [J].
Branza-Nichita, N ;
Petrescu, AJ ;
Dwek, RA ;
Wormald, MR ;
Platt, FM ;
Petrescu, SM .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 261 (03) :720-725